Quantum Biosystems
closedApplication of quantum mechanics to the development of innovative single-molecule DNA sequencers.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | $8.8m | Series C | |
| Total Funding | 000k | ||
Related Content
Quantum Biosystems is at the forefront of genetic data analysis, leveraging quantum sequencing technology to provide precise and rapid DNA measurement. The company serves clients in the biotechnology and healthcare sectors, offering innovative solutions that disrupt traditional genetic sequencing methods. Operating in the global genomics market, Quantum Biosystems employs a business model centered around the commercialization of its proprietary quantum sequencing systems. Revenue is generated through the sale of these systems, as well as through service contracts and partnerships with research institutions and healthcare providers. The company's technology promises to unlock new possibilities in genetic research and personalized medicine.
Keywords: quantum sequencing, genetic data, DNA measurement, biotechnology, healthcare, genomics, innovation, disruptive technology, personalized medicine, research partnerships.